Ovarian Cancer Trial, Recruiting NCT05706922 Sponsor: Erasmus Medical Center Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT05706922
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as Caucasian
  • People who are willing to provide a vaginal swab and a stool (poo) sample
  • People who are willing to give their formal consent to take part in the study
  • People who have a sufficient understanding of the Dutch language
  • People who have been diagnosed with Polycystic Ovary Syndrome (PCOS) at Erasmus MC, confirmed using a recognised set of diagnostic guidelines, by having at least two of the following: signs of higher-than-normal male hormones (either through physical signs or blood test results); irregular or absent periods; or polycystic ovaries shown on a scan

Who may not be able to join:

  • People with a BMI below 18 (considered underweight)
  • People who smoke
  • People who have diabetes or who are taking medication that helps the body use insulin more effectively
  • People with ongoing or current infectious diseases
  • People with a more severe form of endometriosis (classified as stage III or IV)
  • People with elevated levels of the hormone prolactin, or who have a thyroid condition, Cushing's disease, or a gastrointestinal (gut) condition
  • People who have used hormonal contraceptives (such as the pill) or other steroid-based hormones in the past 3 months
  • People who have used antibiotics, probiotics, or laxatives in the past 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sam Schoenmakers, Dr. drs., Division of Obstetrics and Fetal Medicine, Department of Obstetrics and Gynecology

Phone: +31631016348

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Erasmus Medical Center
Registry
ClinicalTrials.gov
Start date
16 November 2023
Est. completion
31 July 2024

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Bacterial composition of the gut in women with PCOS and control group

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov